VANCOUVER, Washington, May 27, 2021 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTC.QB: CYDY), (“CytoDyn” or the “Company"), a late-stage biotechnology company developing Vyrologix™ (leronlimab-PRO 140...
VANCOUVER, Washington, April 07, 2021 (GLOBE NEWSWIRE) -- CytoDyn Inc. (OTC.QB: CYDY), (“CytoDyn” or the “Company"), a late-stage biotechnology company developing leronlimab (PRO 140), a CCR5...
WESTLAKE VILLAGE, Calif. and BELO HORIZONTE, Brazil, June 03, 2019 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq:MNKD) and BIOMM SA (BVMF:BIOM3) today announced that Afrezza® (insulin human...
VALENCIA, Calif. and BELO HORIZONTE, Brazil, May 31, 2017 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq:MNKD) (TASE:MNKD) and BIOMM SA (BVMF:BIOM3) today announced that they have entered...
Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | -0.63 | -7.89473684211 | 7.98 | 8.5 | 7.12 | 56840 | 7.94211119 | CS |
4 | -2.35 | -24.2268041237 | 9.7 | 9.7 | 7.12 | 70868 | 8.37604902 | CS |
12 | -2.53 | -25.6072874494 | 9.88 | 10.66 | 7.12 | 65038 | 9.08639971 | CS |
26 | -6.54 | -47.0842332613 | 13.89 | 16.2 | 7.12 | 91262 | 10.69758027 | CS |
52 | 1.05 | 16.6666666667 | 6.3 | 21.2 | 5 | 104769 | 12.62547931 | CS |
156 | -5.62 | -43.3307632999 | 12.97 | 21.2 | 3.1 | 45680 | 11.32942011 | CS |
260 | -4.65 | -38.75 | 12 | 29 | 3.1 | 38848 | 12.86260223 | CS |
Aucune Discussion Trouvée |
Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales